DFFVX | GSSSX | DFFVX / GSSSX | |
Total Expense Ratio | 0.29 | 1.46 | 20% |
Annual Report Gross Expense Ratio | 0.30 | 1.57 | 19% |
Fund Existence | 26 years | 28 years | - |
Gain YTD | 3.910 | 5.814 | 67% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.3B | 887M | 1,499% |
Annual Yield % from dividends | 1.68 | 0.84 | 201% |
Returns for 1 year | 2.47 | -16.61 | -15% |
Returns for 3 years | 34.38 | -16.90 | -203% |
Returns for 5 years | 91.09 | -15.38 | -592% |
Returns for 10 years | 73.97 | -30.21 | -245% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EMIF | 25.72 | 0.18 | +0.69% |
iShares Emerging Markets Infras ETF | |||
LABD | 32.34 | 0.16 | +0.50% |
Direxion Daily S&P Biotech Bear 3X ETF | |||
REGL | 83.39 | 0.29 | +0.35% |
ProShares S&P MidCap 400 Dividend Arst | |||
DHDG | 33.21 | 0.02 | +0.06% |
FT Vest U.S. Eq Qt 2.5 to 15 Buffr ETF | |||
RIV | 11.58 | -0.07 | -0.60% |
RiverNorth Opportunities Fund |